Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock
21 janv. 2010 18h34 HE
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards,
Inc. today advised that analysis of tumor response data from the OVATURE
trial will be performed in the...
Marshall Edwards, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference
14 janv. 2009 08h59 HE
|
Marshall Edwards, Inc.
WASHINGTON, DC--(Marketwire - January 14, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) will
present at the 27th Annual JPMorgan Healthcare Conference in San Francisco
on Thursday January 15, 2008 at...
Marshall Edwards, Inc. Files IND Application for Triphendiol
01 déc. 2008 08h10 HE
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - December 1, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) today
announced that it has filed an application with the United States Food and
Drug Administration for an...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
13 nov. 2008 08h10 HE
|
Novogen, Limited
NEW CANAAN, CT--(Marketwire - November 13, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
12 nov. 2008 08h10 HE
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial
04 déc. 2007 08h01 HE
|
Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed
Phase Ib clinical trial of a new drug to treat inflammatory bowel disease
(IBD) indicates that treatment may...
Research Indicates Synthetic Compound NV-52 May Be Useful in Treatment of Inflammatory Bowel Disease
13 nov. 2007 08h04 HE
|
Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - November 13, 2007) - An article published
in a recent edition of the peer review journal Expert Opinion, Vol. 16, No.
8, reveals the compound...
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
22 oct. 2007 19h00 HE
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and BERLIN and NEW CANAAN, CT--(Marketwire - October 22, 2007) - A symposium
on platinum resistant ovarian cancer will be held at the European Society
for Gynecological Oncology in...